| abstract |
The invention relates to fatty acid antiviral conjugates comprising an antiviral agent and a fatty acid directly or indirectly covalently linked, wherein the fatty acid is selected from omega-3 fatty acids, fatty acids metabolized in vivo into omega-3 fatty acids, or lipoic acid; compositions comprising an effective amount of a fatty acid antiviral conjugate; and methods for treating or preventing a Hepatitis C, HIV or RSV viral infection comprising the administration of an effective amount of a fatty acid antiviral conjugate. |